An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

NCT02932878 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: DSXS topical

Sponsor

Sun Pharmaceutical Industries, Inc.